Published in Blood Weekly, July 13th, 2006
"They respond differently to chemotherapy, have a different prognosis and are associated with a raised incidence of metachronous lesions if a germline mutation is present," wrote scientists in the journal Colorectal Disease.
According to the authors, "Established methods of detecting mismatch repair gene defects require the testing for microsatellite instability....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.